CHARLOTTESVILLE, Va., April 01, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback